White Paper

Most clinical trials don't fail at patient recruitment

They fail at protocol design.

Health Equity Risk

Download the white paper that's changing how clinical research leaders think about health equity risk, before it costs months and millions.

80% of clinical trials miss their enrolment timelines. In most cases, the cause is traceable and preventable.

When a protocol's eligibility criteria, visit schedule, or site geography silently excludes underserved populations, clinical teams don't find out until recruitment stalls. By then, the protocol is fixed, the sites are contracted, and the budget is set.

How to See Patient Recruitment Failure Before It Happens is a practical framework for VP and Director-level clinical research and operations leaders who want to identify health equity risk before it becomes a delay.
 
In this white paper, you'll find:

Why 80% of clinical trials miss enrolment timelines — and the predictable cause most teams miss

The structural blind spot in EHR, claims, and historic trial data that no amount of data quality fixes

What lived-experience data is and how it closes the gap before protocol sign-off

A health equity risk lens you can apply at each stage of protocol development

Two real-world trial scenarios showing the difference it makes